These conclusions imply that the activation of TLR2, TLR4, TLR9 and MyD88 along with downstream inflammatory signaling pathways are crucial in the development and progression of NAFLD to NASH (Figure 3). This evidence concerns the gene TLR9 and metabolic dysfunction-associated steatotic liver disease.